SCHEMBL23818587

SCHEMBL23818587

CCOC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OC)OC[C@@](C#N)(OC)[C@@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)c1ccc2c(NC(=O)C(C)C)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23818584 0.97 — —
SCHEMBL26333931 0.86 RIPK1 (0.32) —
SCHEMBL23818945 0.86 — —
SCHEMBL23819055 0.82 RIPK1 (0.30) —
SCHEMBL26333018 0.82 RIPK1 (0.30) —
SCHEMBL23818891 0.81 — —
SCHEMBL26332933 0.80 RIPK1 (0.31) —
SCHEMBL23819167 0.80 RIPK1 (0.31) —
SCHEMBL23819180 0.80 RIPK1 (0.31) —
SCHEMBL26333779 0.80 RIPK1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed
Send feedback